Quick Answer
PURPLE BIOTECH LTD. reported Research And Development Expense of $3.73 million for the year ending 2025.
- PURPLE BIOTECH LTD. showed a decrease of -51.0% in Research And Development Expense from 2024 to 2025.
- This data is from PURPLE BIOTECH LTD.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), PURPLE BIOTECH LTD.'s Research And Development Expense has grown by 45.7%.
- Historical annual values: Fiscal year 2025: $3.73 million | Fiscal year 2024: $7.62 million | Fiscal year 2023: $17.03 million | Fiscal year 2022: $16.32 million | Fiscal year 2021: $11.83 million | Fiscal year 2020: $7.24 million | Fiscal year 2019: $2.28 million | Fiscal year 2018: $5.27 million | Fiscal year 2017: $4.64 million | Fiscal year 2016: $4.18 million | Fiscal year 2015: $2.56 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: